ELISpot and FluoroSpot Assay Market worth USD 287 million by 2023, at a CAGR of 16.2%
The ELISpot and
FluoroSpot market is projected to reach USD 287 million by 2023 from USD 135
million in 2018, at a CAGR of 16.2% during the forecast period.
Growth in ELISpot
and FluoroSpot market is driven by the rising global incidence of chronic
diseases, increasing vaccine development to address the challenge of
antimicrobial resistance, and technological advancements in ELISpot and
FluoroSpot...
ELISpot and FluoroSpot Assay Market | Oxford Immunotec, Cellular Technologies, Mabtech, BD, Abcam
Growth in this ELISpot and FluoroSpot Assay Market is driven
by the rising global incidence of chronic diseases, increasing vaccine
development to address the challenge of antimicrobial resistance, and
technological advancements in ELISpot and FluoroSpot assay kits and analyzers.
[111 Pages Report]
The ELISpot and FluoroSpot Assay market is projected to reach USD 287 million by
2023 from USD 135...